Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies

• Hoofdauteurs: Adam Hermawan (Auteur), Muthi Ikawati (Auteur), Riris Istighfari Jenie (Auteur), Annisa Khumaira (Auteur), Herwandhani Putri (Auteur), Ika Putri Nurhayati (Auteur), Sonia Meta Angraini (Auteur), Haruma Anggraini Muflikhasari (Auteur)
• Formaat: Boek
• Gepubliceerd in: Elsevier, 2021-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Cancer therapy is a strategic measure in inhibiting breast cancer stem cell (BCSC) pathways. Naringenin, a citrus flavonoid, was found to increase breast cancer cells' sensitivity to chemotherapeutic agents. Bioinformatics study and 3D tumorsphere in vitro modeling in breast cancer (mammosphere...